What would you do with £70,000 (approximately $100,000) to help people living with multiple myeloma?
What would you do with £70,000 (approximately $100,000) to help people living with multiple myeloma?
Join our efforts to target a better future for the multiple myeloma community
GlaxoSmithKline (GSK) is driving progress for the multiple myeloma community though new research and therapeutic approaches, as well as programmes within the community. As part of this effort, GSK has launched the Target the Future Think Tank Challenge to grant £70,000 (approximately $100,000) to an individual or non-profit organisation who develops the most innovative idea that addresses the unmet needs of patients with multiple myeloma. While the current submission deadline has passed, you can still learn more about the Target the Future Think Tank Challenge and how to apply for the next Challenge.
Here are some of the
key challenges and
issues we are trying
to address:
Understanding
options at
every step
Getting to the
right care
Relieving
the emotional
burden
Addressing
disparities
and inequities
in care
Together we can change lives
Learn more about unmet needs from people committed to targeting a better future for the multiple myeloma community.
Innovation in multiple myeloma
Novel treatment targets open a world of possibilities for patients. GSK is working to apply these discoveries to improve the well-being of multiple myeloma patients.